共 91 条
[1]
Sauer R(2004)Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 1731-1740
[2]
Becker H(2004)Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy J Clin Oncol 22 3958-3964
[3]
Hohenberger W(2005)Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer Ann Surg 241 829-836
[4]
van den Brink M(2006)Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 1114-1123
[5]
Stiggelbout AM(2007)The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma Ann Surg 246 693-701
[6]
van den Hout WB(2014)Programmed death-1 pathway in cancer and autoimmunity Clin Immunol 153 145-152
[7]
Guillem JG(2014)PD-1 pathway inhibitors: changing the landscape of cancer immunotherapy Cancer Control 21 231-237
[8]
Chessin DB(2010)The PD-1 pathway in tolerance and autoimmunity Immunol Rev 236 219-242
[9]
Cohen AM(2006)Tissue expression of PD-L1 mediates peripheral T cell tolerance J Exp Med 203 883-895
[10]
Bosset JF(2008)PD-1 and its ligands in tolerance and immunity Annu Rev Immunol 26 677-704